113 related articles for article (PubMed ID: 9178172)
1. Expression of p53, Ki-67 and cytokeratin-4 (CK4) in oral papillomas.
Copete MA; Wendt K; Chen SY
J Oral Pathol Med; 1997 May; 26(5):211-6. PubMed ID: 9178172
[TBL] [Abstract][Full Text] [Related]
2. PCNA and P53 expression in relation to clinicopathological features of oral papilloma.
Sulkowska M; Famulski W; Stasiak-Barmuta A; Kasacka I; Koda M; Chyczewski L; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():193-4. PubMed ID: 11820603
[TBL] [Abstract][Full Text] [Related]
3. [Expression of p53 and Ki-67 genes in epithelial dysplasia from old oral mucosa and clinical significance].
Zhao J; Guo B; Ma SC; Zhou XD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):689-91. PubMed ID: 16235539
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of ras p21 in oral papilloma.
Satoh M; Hatakeyama S; Sashima M; Suzuki A
J Oral Pathol Med; 1990 Nov; 19(10):490-1. PubMed ID: 2286930
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ki-67, tumor suppressor proteins, growth factor, and growth factor receptor in juvenile respiratory papillomatosis: Ki-67 and p53 as predictors of aggressive disease.
Stern Y; Heffelfinger SC; Walner DL; Cotton RT
Otolaryngol Head Neck Surg; 2000 Mar; 122(3):378-86. PubMed ID: 10699815
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas.
Hafian H; Venteo L; Sukhanova A; Nabiev I; Lefevre B; Pluot M
Hum Pathol; 2004 Jun; 35(6):745-51. PubMed ID: 15188142
[TBL] [Abstract][Full Text] [Related]
7. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization.
Teifke JP; Löhr CV; Shirasawa H
Vet Microbiol; 1998 Feb; 60(2-4):119-30. PubMed ID: 9646444
[TBL] [Abstract][Full Text] [Related]
8. Immunodetection of keratin proteins in oral epithelial neoplasms.
Narayana N; Gadewar D
Indian J Dent Res; 1992; 3(3):68-75. PubMed ID: 1285339
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO
Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163
[TBL] [Abstract][Full Text] [Related]
10. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
11. Epithelial growth fraction and expression of p53 tumour suppressor gene in oral submucous fibrosis.
Cox SC; Walker DM
Aust Dent J; 1996 Apr; 41(2):91-6. PubMed ID: 8670041
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
13. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of c-myc oncogene product in oral papilloma.
Satoh M; Sashima M; Hatakeyama S; Yoshimura N; Otsu T; Suzuki A
J Oral Pathol Med; 1992 Mar; 21(3):97-9. PubMed ID: 1583601
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
17. Nucleophosmin, p53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray.
Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
Hum Pathol; 2010 Aug; 41(8):1079-86. PubMed ID: 20338617
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical analysis of AE1/AE3, CK 14, Ki-67 and p53 expression in benign, premalignant and malignant oral tissue to establish putative markers for progression of oral carcinoma.
Farrar M; Sandison A; Peston D; Gailani M
Br J Biomed Sci; 2004; 61(3):117-24. PubMed ID: 15462255
[TBL] [Abstract][Full Text] [Related]
19. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
[TBL] [Abstract][Full Text] [Related]
20. The expression of tumorigenesis markers in oral papilloma.
Reszeć J; Sulkowska M; Famulski W; Guzińska-Ustymowicz K; Sulkowski S
Pol J Pathol; 2002; 53(4):195-200. PubMed ID: 12597336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
